Inhibitors of sterol synthesis. Metabolism of 5 alpha-cholest-8(14)-en-3 beta-ol-15-one after intravenous administration to bile duct-cannulated rats. 1988

G J Schroepfer, and A J Chu, and D H Needleman, and A Izumi, and P T Nguyen, and K S Wang, and J M Little, and B C Sherrill, and A Kisic
Department of Biochemistry, Rice University, Houston, Texas 77251.

The metabolism of 5 alpha-cholest-8(14)-en-3 beta-ol-15-one has been studied after intravenous administration to bile duct-cannulated rats. Very rapid and substantial conversion of the 15-ketosterol to polar biliary metabolites was observed in both male and female rats. For example, upon intravenous injection of [4-14C]5 alpha-cholest-8(14)-en-3 beta-ol-15-one to male bile duct-cannulated rats, approximately 86% of the administered 14C was recovered in bile in the first 38 h. Of the total amount of 14C recovered in bile in 38 h, approximately 50% was excreted in bile in the first 70 min and approximately 90% was excreted within 8 h after the injection of the 15-ketosterol. A substantial fraction of the polar biliary metabolites was shown to undergo enterohepatic circulation. Of the radioactivity derived from the labeled 15-ketosterol which was not recovered in bile or other excreta at 48 h after the intravenous administration of the 15-ketosterol, most (approximately 79%) was recovered in the form of cholesterol and cholesteryl esters of blood and the various tissues. The very substantial and rapid biliary excretion of polar metabolites of the 15-ketosterol (or of cholesterol derived from the 15-ketosterol), coupled with inhibition of the intestinal absorption of cholesterol by the 15-ketosterol, may contribute to the overall hypocholesterolemic action of the 15-ketosterol which has been observed in rodents and in nonhuman primates by providing a metabolic pathway(s) wherein a substantial fraction of the absorbed 15-ketosterol is rapidly removed from the body by biliary excretion in the form of polar metabolites.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008297 Male Males
D002404 Catheterization Use or insertion of a tubular device into a duct, blood vessel, hollow organ, or body cavity for injecting or withdrawing fluids for diagnostic or therapeutic purposes. It differs from INTUBATION in that the tube here is used to restore or maintain patency in obstructions. Cannulation,Cannulations,Catheterizations
D002782 Cholestenes Steroids with methyl groups at C-10 and C-13 and a branched 8-carbon chain at C-17. Members include compounds with any degree of unsaturation; however, CHOLESTADIENES is available for derivatives containing two double bonds.
D002783 Cholestenones CHOLESTENES with one or more double bonds and substituted by any number of keto groups.
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D004386 Duodenum The shortest and widest portion of the SMALL INTESTINE adjacent to the PYLORUS of the STOMACH. It is named for having the length equal to about the width of 12 fingers. Duodenums
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001646 Bile An emulsifying agent produced in the LIVER and secreted into the DUODENUM. Its composition includes BILE ACIDS AND SALTS; CHOLESTEROL; and ELECTROLYTES. It aids DIGESTION of fats in the duodenum. Biliary Sludge,Sludge, Biliary

Related Publications

G J Schroepfer, and A J Chu, and D H Needleman, and A Izumi, and P T Nguyen, and K S Wang, and J M Little, and B C Sherrill, and A Kisic
May 1988, Chemistry and physics of lipids,
G J Schroepfer, and A J Chu, and D H Needleman, and A Izumi, and P T Nguyen, and K S Wang, and J M Little, and B C Sherrill, and A Kisic
March 1989, Chemistry and physics of lipids,
G J Schroepfer, and A J Chu, and D H Needleman, and A Izumi, and P T Nguyen, and K S Wang, and J M Little, and B C Sherrill, and A Kisic
August 1987, Biochemical and biophysical research communications,
G J Schroepfer, and A J Chu, and D H Needleman, and A Izumi, and P T Nguyen, and K S Wang, and J M Little, and B C Sherrill, and A Kisic
November 1987, Journal of lipid research,
G J Schroepfer, and A J Chu, and D H Needleman, and A Izumi, and P T Nguyen, and K S Wang, and J M Little, and B C Sherrill, and A Kisic
February 1992, Journal of medicinal chemistry,
G J Schroepfer, and A J Chu, and D H Needleman, and A Izumi, and P T Nguyen, and K S Wang, and J M Little, and B C Sherrill, and A Kisic
January 1988, Steroids,
G J Schroepfer, and A J Chu, and D H Needleman, and A Izumi, and P T Nguyen, and K S Wang, and J M Little, and B C Sherrill, and A Kisic
April 1980, Biochemical and biophysical research communications,
G J Schroepfer, and A J Chu, and D H Needleman, and A Izumi, and P T Nguyen, and K S Wang, and J M Little, and B C Sherrill, and A Kisic
January 1989, Toxicologic pathology,
G J Schroepfer, and A J Chu, and D H Needleman, and A Izumi, and P T Nguyen, and K S Wang, and J M Little, and B C Sherrill, and A Kisic
November 1987, Journal of lipid research,
G J Schroepfer, and A J Chu, and D H Needleman, and A Izumi, and P T Nguyen, and K S Wang, and J M Little, and B C Sherrill, and A Kisic
February 1989, Journal of lipid research,
Copied contents to your clipboard!